Article Text

PDF
Relapsing hypocupraemic myelopathy requiring high-dose oral copper replacement
  1. C I Prodan1,
  2. S S Bottomley2,
  3. N R Holland4,
  4. S E Lind3
  1. 1Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
  2. 2Department of Medicine, University of Oklahoma Health Sciences Center
  3. 3Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA
  4. 4Neurology Specialists of Monmouth County, West Longbranch, New Jersey, USA
  1. Correspondence to:
 C I Prodan
 711 S.L. Young Boulevard, PPOB, Suite 215, Oklahoma City, OK 73104, USA; calin-prodan{at}ouhsc.edu

Abstract

Adult-onset copper deficiency with neurological manifestations is a newly recognised syndrome. Long-term oral copper replacement therapy has been the mainstay of treatment in the literature. A case of relapsing hypocupraemic myelopathy responsive to increased doses of copper replacement is reported. Standard doses of copper may not be sufficient for all patients.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Informed consent was obtained for publication of the patient’s details described in this report.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.